# Haystack Oncology, Inc. — Form D

Haystack Oncology, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-16. The offering totals $67.0M, of which $67.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-11-16
- Form: D
- Accession: 0001952610-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $67.0M
- Amount sold: $67.0M
- Investors: 6
- Date of first sale: 2022-10-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-464948

## Issuer

- Name: Haystack Oncology, Inc.
- CIK: 0001952610
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 301 W 29TH STREET, BALTIMORE, MD, 21211
- Phone: 4102971000

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Dan Edelstein | Director | BALTIMORE, MD |
| Nickolas Papadopoulos | Director | BALTIMORE, MD |
| George Petrocheilos | Director | Baltimore, MD |
| Isaac Ro | Director | San Mateo, CA |
| R. Jacob Vogelstein | Director | Cambridge, MA |
| Dan Edelstein | Executive Officer | BALTIMORE, MD |
| Olga Maltseva | Executive Officer | New York, NY |
| Nickolas Papadopoulos | Executive Officer | BALTIMORE, MD |

## More

- [CIK 1952610 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1952610&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001952610-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.